Vida Lung

VIDA (vidalung.ai) provides data-driven, AI-powered clinical trial imaging for pharmaceutical and life-sciences sponsors. Its offering is delivered through the VIDA Intelligence Platform, which enables sponsors to collect and leverage imaging data across drug development and the clinical trial process. Service lines span clinical trial imaging, clinical development planning, and therapeutic research.

Within clinical trial imaging, VIDA performs image analysis that combines radiology assessments (eligibility reads, safety reads, adjudication) with AI algorithms that produce quantitative imaging biomarkers; it also handles site management, including digital site onboarding, site training, scanner certification and ongoing site support, and gives sponsors platform access to trial imaging data, key performance metrics and site activity. Clinical development planning services cover trial workflow design, biomarker and site selection, matching sponsors to high-performing sites (including a network of freestanding imaging facilities that can be paired with trial centers lacking imaging capability), and construction of external control arms and digital twins from its data assets. Therapeutic research services let sponsors and researchers examine cohorts through disease phenotyping, biomarker discovery and retrospective analysis of existing imaging datasets.

VIDA also positions a "Digital Biobank" product, described as the digital analogue of a tissue or blood biobank, holding longitudinal patient information such as imaging data, test results, demographics and diagnoses, and used to reveal patterns among responder cohorts, identify early disease phenotypes and therapeutic targets, and simulate control arms or digital twins.

Business model

VIDA sells platform-enabled imaging services to clinical trial sponsors, spanning trial imaging execution, expert reading services, development planning and research access to its data repositories, including the Digital Biobank.